Phreesia (NYSE:PHR) Stock Price Up 7.9% – Still a Buy?

Shares of Phreesia, Inc. (NYSE:PHR) traded up 7.9% on Tuesday . The company traded as high as $28.97 and last traded at $29.11. 367,600 shares changed hands during mid-day trading, a decline of 2% from the average session volume of 376,616 shares. The stock had previously closed at $26.98.

Analyst Upgrades and Downgrades

Several research firms have issued reports on PHR. Citigroup boosted their price objective on shares of Phreesia from $31.00 to $35.00 and gave the company a “buy” rating in a research report on Friday, January 10th. KeyCorp boosted their price target on shares of Phreesia from $28.00 to $30.00 and gave the company an “overweight” rating in a report on Wednesday, January 8th. Truist Financial boosted their price target on Phreesia from $31.00 to $34.00 and gave the stock a “buy” rating in a research report on Wednesday, December 11th. Royal Bank of Canada raised shares of Phreesia from a “sector perform” rating to an “outperform” rating and increased their target price for the company from $24.00 to $32.00 in a research report on Wednesday, January 8th. Finally, Robert W. Baird reduced their price target on Phreesia from $34.00 to $30.00 and set an “outperform” rating on the stock in a research report on Wednesday, December 11th. Twelve analysts have rated the stock with a buy rating, Based on data from MarketBeat, the stock currently has an average rating of “Buy” and an average target price of $31.00.

Phreesia Stock Performance

The company has a market capitalization of $1.70 billion, a PE ratio of -19.90 and a beta of 0.94. The firm has a 50-day moving average of $24.36 and a two-hundred day moving average of $23.15. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.04.

Phreesia (NYSE:PHR) last issued its quarterly earnings results on Monday, December 9th. The company reported ($0.25) EPS for the quarter, topping the consensus estimate of ($0.29) by $0.04. Phreesia had a negative net margin of 20.43% and a negative return on equity of 32.78%. The company had revenue of $106.80 million during the quarter, compared to analyst estimates of $106.33 million. During the same quarter in the previous year, the firm earned ($0.58) EPS. The firm’s revenue was up 16.6% compared to the same quarter last year. Research analysts anticipate that Phreesia, Inc. will post -1.1 EPS for the current year.

Insider Transactions at Phreesia

In related news, CFO Balaji Gandhi sold 5,827 shares of the stock in a transaction that occurred on Tuesday, January 21st. The stock was sold at an average price of $27.31, for a total value of $159,135.37. Following the completion of the transaction, the chief financial officer now directly owns 141,846 shares in the company, valued at approximately $3,873,814.26. This represents a 3.95 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Michael Weintraub sold 15,152 shares of Phreesia stock in a transaction on Monday, December 2nd. The shares were sold at an average price of $21.01, for a total value of $318,343.52. Following the completion of the sale, the director now owns 242,827 shares in the company, valued at $5,101,795.27. This represents a 5.87 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 131,883 shares of company stock worth $3,248,465 in the last quarter. Company insiders own 5.80% of the company’s stock.

Institutional Trading of Phreesia

A number of institutional investors and hedge funds have recently bought and sold shares of the business. R Squared Ltd purchased a new position in Phreesia in the fourth quarter valued at $30,000. International Assets Investment Management LLC boosted its position in shares of Phreesia by 2,179.7% during the 3rd quarter. International Assets Investment Management LLC now owns 1,459 shares of the company’s stock worth $33,000 after acquiring an additional 1,395 shares in the last quarter. XTX Topco Ltd purchased a new position in shares of Phreesia in the 3rd quarter valued at about $247,000. Hsbc Holdings PLC purchased a new stake in Phreesia during the second quarter worth approximately $301,000. Finally, Intech Investment Management LLC acquired a new stake in Phreesia during the third quarter worth approximately $316,000. 92.10% of the stock is currently owned by hedge funds and other institutional investors.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.